But all the cries over the "new logo" seem a little ridiculous, as the rest of the line has Slipknot's classic "S" logo. So it's not like they rolled out a whole new merch line that was clearly ...

Many people do not understand dark humour, let alone dark orphan jokes. Such jokes add a funny twist on sad subjects such as death, which are considered taboo. Here is a list of dark humour jokes ...

The headlining act, Slipknot, will be returning to Australia as part of their 25th-anniversary tour, celebrating the release of their groundbreaking 1999 debut album. Fans can expect a setlist packed ...

Other highlights from the day included Till Lindemann of Rammstein, Ministry, and Halestorm. Slipknot headlined Day 2 of the festival, playing a 1999-era set. The band are currently celebrating the ...

It’s here! The Knotfest Australia 2025 lineup has arrived in all its glory and, as promised, Slipknot themselves are coming back to headline. Other big names on the roster for the Aussie leg of ...

It’s here! The Knotfest Australia 2025 lineup has arrived in all its glory and, as promised, Slipknot themselves are coming back to headline. The international-heavy lineup will also see sets ...

“The FDA’s granting of orphan drug designation for IMM-1-104 underscores the urgent need for new therapies that meaningfully improve outcomes for pancreatic cancer patients and represents an ...

In 2011, Alice looked back over a career in upsetting the authorities. In the history of rock’n’roll, there have been many larger-than-life characters, from Kiss to Slipknot. But no star has divided ...

Continuing the 25th anniversary tour celebrating their majestic self-titled debut album, Slipknot understand tonight’s assignment and they’re ready to kick it off. Eyeless follows, eliciting a feral ...

Americans’ fixation with self-reliance has taught us that we can do everything alone. Yet as more Americans have chosen to live a single and childless life to focus on their careers and personal life ...

Orphan drug status, a status designated by the Food and Drug Administration (FDA), gives companies researching cures for rare diseases a seven-year window of exclusive marketing rights post ...